The Food and Drug Administration has delayed a promised review of safety data for the abortion drug mifepristone at ...
Food and Drug Administration Commissioner Marty Makary is under renewed scrutiny by Trump officials amid continued turmoil at ...
It’s getting out of control. It’s distorting the doctor-patient relationship, these endless pharmaceutical ads,” Makary told ...
All this data builds Jefferies’ argument: the FDA change could help boost return on investment and therefore drive R&D spend.
The FDA plans to begin requiring one clinical study, instead of the standard two, for medical products before consideration ...
Commissioner Marty Makary said that the FDA will soon start requiring only one pivotal trial, instead of two, for companies ...
Myocarditis is a known — but small — side effect of the mRNA Covid vaccines from Pfizer and Moderna, information that federal ...
Makary, a former professor at the Johns Hopkins School of Medicine, explained to “Pod Force One” host Miranda Devine that as ...
No new data supports these label changes, which fly in the face of known science. More than 100,000 women in Kansas City and ...
Høeg, a COVID-19 vaccine critic who’s been serving as a special assistant to the commissioner, will be the fifth person this ...
The U.S. Food and Drug Administration (FDA) has been rocked by recent changes to several leadership roles while it has ...
Peter Pitts, a former associate commissioner of the FDA, joins "CUOMO" to discuss the resignation of Dr. Richard Pazdur, the ...